G. Shanmugam

1.7k total citations
76 papers, 1.5k citations indexed

About

G. Shanmugam is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, G. Shanmugam has authored 76 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 15 papers in Oncology and 12 papers in Genetics. Recurrent topics in G. Shanmugam's work include Cancer-related Molecular Pathways (10 papers), DNA Repair Mechanisms (8 papers) and Virus-based gene therapy research (7 papers). G. Shanmugam is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), DNA Repair Mechanisms (8 papers) and Virus-based gene therapy research (7 papers). G. Shanmugam collaborates with scholars based in India, United States and Japan. G. Shanmugam's co-authors include Nobuo Tsuchida, Viswanathan Muthusamy, Pushpa M. Bhargava, Maurice Green, Saumya Bhaduri, Arasambattu Kannan Munirajan, V. Krishnakumar, A. Mohankumar, P. Sundararaj and K Kannan and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Biochemistry.

In The Last Decade

G. Shanmugam

73 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Shanmugam India 24 846 270 248 182 154 76 1.5k
Jingwen Luo China 20 682 0.8× 74 0.3× 244 1.0× 94 0.5× 95 0.6× 49 1.5k
Alan Soo Beng Khoo Malaysia 22 1.3k 1.5× 113 0.4× 545 2.2× 63 0.3× 43 0.3× 66 2.2k
Yongtao Li China 23 583 0.7× 100 0.4× 175 0.7× 67 0.4× 42 0.3× 98 1.3k
Sarika Sharma India 19 417 0.5× 41 0.2× 124 0.5× 102 0.6× 104 0.7× 69 1.2k
Naoya Kitamura Japan 22 617 0.7× 80 0.3× 217 0.9× 28 0.2× 70 0.5× 64 1.5k
Young Soo Song South Korea 20 405 0.5× 52 0.2× 227 0.9× 96 0.5× 90 0.6× 64 1.4k
Hua Pei China 19 635 0.8× 33 0.1× 223 0.9× 183 1.0× 112 0.7× 83 1.2k
Xiaochun Xu United States 26 1.2k 1.4× 455 1.7× 604 2.4× 26 0.1× 39 0.3× 67 2.4k
Nicholas P. Ambulos United States 17 573 0.7× 229 0.8× 67 0.3× 39 0.2× 59 0.4× 50 842
Saber İmani China 23 776 0.9× 83 0.3× 276 1.1× 84 0.5× 68 0.4× 81 1.5k

Countries citing papers authored by G. Shanmugam

Since Specialization
Citations

This map shows the geographic impact of G. Shanmugam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Shanmugam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Shanmugam more than expected).

Fields of papers citing papers by G. Shanmugam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Shanmugam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Shanmugam. The network helps show where G. Shanmugam may publish in the future.

Co-authorship network of co-authors of G. Shanmugam

This figure shows the co-authorship network connecting the top 25 collaborators of G. Shanmugam. A scholar is included among the top collaborators of G. Shanmugam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Shanmugam. G. Shanmugam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shanmugam, G., et al.. (2023). Influence of Eu3+ dopant on the third order nonlinear optical properties of PbO/PMMA nanocomposites. Materials Research Innovations. 27(6). 433–440. 1 indexed citations
2.
Mohankumar, A., G. Shanmugam, F. Dallemer, et al.. (2018). Organoruthenium(II) Complexes Ameliorates Oxidative Stress and Impedes the Age Associated Deterioration in Caenorhabditis elegans through JNK-1/DAF-16 Signalling. Scientific Reports. 8(1). 7688–7688. 24 indexed citations
3.
Krishnamurthy, Jairam, et al.. (2001). Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. Oral Oncology. 37(3). 222–224. 22 indexed citations
4.
Shanmugam, G., et al.. (2000). Cleistanthin A, a diphyllin glycoside from Cleistanthus collinus, is cytotoxic to PHA‐stimulated (proliferating) human lymphocytes. Drug Development Research. 51(3). 187–190. 1 indexed citations
5.
Kannan, K, et al.. (2000). FHIT Gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncology. 36(2). 189–193. 13 indexed citations
6.
Kannan, K, et al.. (1999). Infrequent genetic alterations of p53, p16 genes and polymorphism in fhit gene in Indian myelodysplastic syndrome.. PubMed. 11(2). 101–4. 2 indexed citations
7.
Munirajan, Arasambattu Kannan, K Kannan, V. Bhuvarahamurthy, et al.. (1998). The Status of Human Papillomavirus and Tumor Suppressor Genesp53andp16in Carcinomas of Uterine Cervix from India. Gynecologic Oncology. 69(3). 205–209. 31 indexed citations
8.
Kumar, Chandan, Gopal Pande, & G. Shanmugam. (1998). Cleistanthin B causes G1 arrest and induces apoptosis in mammalian cells. APOPTOSIS. 3(6). 413–419. 16 indexed citations
9.
Munirajan, Arasambattu Kannan, et al.. (1996). p53 gene mutations in oral carcinomas from India. International Journal of Cancer. 66(3). 297–300. 5 indexed citations
10.
Munirajan, Arasambattu Kannan, et al.. (1996). p53 gene mutations in oral carcinomas from India. International Journal of Cancer. 66(3). 297–300. 51 indexed citations
11.
Shanmugam, G., et al.. (1995). Genotoxicity of the herbicide butachlor in cultured human lymphocytes. Mutation Research/Genetic Toxicology. 344(1-2). 63–67. 30 indexed citations
12.
Subramaniam, Malayannan & G. Shanmugam. (1989). Effects of serum, cycloheximide and actinomycin D on protein secretion by quiescent mouse embryo fibroblasts. Molecular Biology Reports. 13(3). 133–138. 4 indexed citations
13.
Nagashunmugam, Thandavarayan & G. Shanmugam. (1987). S phase mouse embryo fibroblasts secrete varying amounts of a 45000 Dalton protein. Cell Biology International Reports. 11(3). 147–155. 6 indexed citations
14.
Subramaniam, Malayannan & G. Shanmugam. (1986). A serum-induced 29 Kd protein of mouse embryo fibroblasts is tightly bound to the chromatin. Cell Biology International Reports. 10(5). 323–329. 6 indexed citations
15.
Shanmugam, G., et al.. (1984). DNA-binding proteins of human placenta: purification and characterization of an endonuclease. Molecular Biology Reports. 10(2). 91–97. 6 indexed citations
16.
Shanmugam, G.. (1979). Subcellular distribution of newly synthesized virus-specific polypeptides in Moloney murine leukemia virus infected cells. Journal of Virology. 29(1). 385–389. 1 indexed citations
17.
Gilead, Zvee, et al.. (1976). Synthesis of the adenovirus-coded DNA binding protein in infected cells. Journal of Virology. 18(2). 454–460. 17 indexed citations
18.
Shanmugam, G., Giancarlo Vecchio, Domenica Gandini Attardi, & Maurice Green. (1972). Immunological Studies on Viral Polypeptide Synthesis in Cells Replicating Murine Sarcoma-Leukemia Virus. Journal of Virology. 10(3). 447–455. 38 indexed citations
19.
Bhargava, Pushpa M. & G. Shanmugam. (1971). Uptake of Nonviral Nucleic Acids by Mammalian Cells. Progress in nucleic acid research and molecular biology. 11. 103–192. 80 indexed citations
20.
Shanmugam, G. & Purnima Bhargava. (1968). The effect of actinomycin D on the synthesis of ribonucleic acid and protein in rat liver parenchymal cells in suspension and liver slices. Biochemical Journal. 108(5). 741–748. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026